BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11054522)

  • 1. A quantitative treatment planning study evaluating the potential of dose escalation in conformal radiotherapy of the oesophagus.
    Bedford JL; Viviers L; Guzel Z; Childs PJ; Webb S; Tait DM
    Radiother Oncol; 2000 Nov; 57(2):183-93. PubMed ID: 11054522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation.
    Grills IS; Yan D; Martinez AA; Vicini FA; Wong JW; Kestin LL
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):875-90. PubMed ID: 14529795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
    Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of conventional and conformal radiotherapy of the oesophagus: work in progress.
    Guzel Z; Bedford JL; Childs PJ; Nahum AE; Webb S; Oldham M; Tait D
    Br J Radiol; 1998 Oct; 71(850):1076-82. PubMed ID: 10211069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
    van Der Wel A; Nijsten S; Hochstenbag M; Lamers R; Boersma L; Wanders R; Lutgens L; Zimny M; Bentzen SM; Wouters B; Lambin P; De Ruysscher D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):649-55. PubMed ID: 15708242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional PET/CT in week 5-6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
    Gillham C; Zips D; Pönisch F; Evers C; Enghardt W; Abolmaali N; Zöphel K; Appold S; Hölscher T; Steinbach J; Kotzerke J; Herrmann T; Baumann M
    Radiother Oncol; 2008 Sep; 88(3):335-41. PubMed ID: 18514339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-dimensional treatment planning for postoperative radiotherapy in patients with node-positive cervical cancer. Comparison between a conventional and a conformal technique.
    Olofsen-van Acht MJ; Quint S; Seven M; van Santvoort JP; van den Berg HA; Logmans A; Levendag PC
    Strahlenther Onkol; 1999 Sep; 175(9):462-9. PubMed ID: 10518981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose escalation of radical radiation therapy in non-small-cell lung cancer using positron emission tomography/computed tomography-defined target volumes: are class solutions obsolete?
    Everitt S; Schneider-Kolsky M; Yuen K; Budd R; Mac Manus M
    J Med Imaging Radiat Oncol; 2008 Apr; 52(2):168-77. PubMed ID: 18373810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of heart and coronary artery doses associated with intensity-modulated radiotherapy versus three-dimensional conformal radiotherapy for distal esophageal cancer.
    Kole TP; Aghayere O; Kwah J; Yorke ED; Goodman KA
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1580-6. PubMed ID: 22284687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhomogeneous dose escalation increases expected local control for NSCLC patients with lymph node involvement without increased mean lung dose.
    Nielsen TB; Hansen O; Schytte T; Brink C
    Acta Oncol; 2014 Jan; 53(1):119-25. PubMed ID: 23627917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensity-modulated radiotherapy for locally advanced non-small-cell lung cancer: a dose-escalation planning study.
    Lievens Y; Nulens A; Gaber MA; Defraene G; De Wever W; Stroobants S; Van den Heuvel F;
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):306-13. PubMed ID: 20888706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy for lung cancer: target splitting by asymmetric collimation enables reduction of radiation doses to normal tissues and dose escalation.
    Wurstbauer K; Deutschmann H; Kranzinger M; Merz F; Rahim H; Sedlmayer F; Kogelnik HD
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):333-41. PubMed ID: 10760428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
    Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of conformal and intensity-modulated techniques for oesophageal radiotherapy.
    Nutting CM; Bedford JL; Cosgrove VP; Tait DM; Dearnaley DP; Webb S
    Radiother Oncol; 2001 Nov; 61(2):157-63. PubMed ID: 11690681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of conformal thoracic radiotherapy using cone-beam CT imaging for treatment verification.
    Sidhu K; Ford EC; Spirou S; Yorke E; Chang J; Mueller K; Todor D; Rosenzweig K; Mageras G; Chui C; Ling CC; Amols H
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):757-67. PubMed ID: 12573763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer.
    Amer AM; Mott J; Mackay RI; Williams PC; Livsey J; Logue JP; Hendry JH
    Int J Radiat Oncol Biol Phys; 2003 May; 56(1):199-207. PubMed ID: 12694839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The theoretical benefit of beam fringe compensation and field size reduction for iso-normal tissue complication probability dose escalation in radiotherapy of lung cancer.
    Engelsman M; Remeijer P; van Herk M; Mijnheer B; Damen E
    Med Phys; 2003 Jun; 30(6):1086-95. PubMed ID: 12852532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse planning in three-dimensional conformal and intensity-modulated radiotherapy of mid-thoracic oesophageal cancer.
    Wu VW; Sham JS; Kwong DL
    Br J Radiol; 2004 Jul; 77(919):568-72. PubMed ID: 15238403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhomogeneous target-dose distributions: a dimension more for optimization?
    De Gersem WR; Derycke S; Colle CO; De Wagter C; De Neve WJ
    Int J Radiat Oncol Biol Phys; 1999 May; 44(2):461-8. PubMed ID: 10760444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.